Compare NRXP & MED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NRXP | MED |
|---|---|---|
| Founded | 2015 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 151.1M | 133.7M |
| IPO Year | 2017 | 1996 |
| Metric | NRXP | MED |
|---|---|---|
| Price | $2.68 | $12.04 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $38.50 | N/A |
| AVG Volume (30 Days) | ★ 537.4K | 114.2K |
| Earning Date | 11-16-2026 | 10-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 69.70 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,225,000.00 | ★ $934,842,000.00 |
| Revenue This Year | $357.94 | N/A |
| Revenue Next Year | $1,507.30 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.65 | $9.22 |
| 52 Week High | $5.06 | $13.58 |
| Indicator | NRXP | MED |
|---|---|---|
| Relative Strength Index (RSI) | 32.34 | 60.56 |
| Support Level | $1.68 | $9.99 |
| Resistance Level | $3.62 | $13.30 |
| Average True Range (ATR) | 0.13 | 0.26 |
| MACD | -0.02 | 0.04 |
| Stochastic Oscillator | 35.40 | 100.00 |
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.